CellArtgen Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
21
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$2.74M
- Investors
-
6
CellArtgen General Information
Description
Developer of regenerative therapeutics designed to treat diseases by replacing tissues and organs of the human body. The company's therapeutics reflect the genetic characteristics of each tissue that makes up the actual organ, and the arrangement of cells is similar to that of a real organ, enabling healthcare professionals to potentially treat nonalcoholic steatohepatitis, Alzheimer's disease, and pulmonary fibrosis.
Contact Information
Website
cellartgen.com/kor/mainCorporate Office
- 332 ABC, Yonsei University Engineering Building
- 50 Yonsei-ro, Seodaemun-gu
- Seoul
- South Korea
Corporate Office
- 332 ABC, Yonsei University Engineering Building
- 50 Yonsei-ro, Seodaemun-gu
- Seoul
- South Korea
CellArtgen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 01-Dec-2025 | $2.74M | Completed | Generating Revenue | ||
| 3. Early Stage VC | 01-May-2022 | Completed | Generating Revenue | |||
| 2. Seed Round | 07-Sep-2021 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | 01-Sep-2021 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
CellArtgen Signals
CellArtgen Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| iAccel (Seongnam-si) | Venture Capital | Minority | ||
| Moneyball Ventures | Venture Capital | Minority | ||
| Ray (Diagnostic Equipment) | Corporation | Minority | ||
| Seoul National University Technology Holdings | Accelerator/Incubator | Minority | ||
| Yeonsei Technology Holdings | Holding Company | Minority |
CellArtgen FAQs
-
When was CellArtgen founded?
CellArtgen was founded in 2020.
-
Where is CellArtgen headquartered?
CellArtgen is headquartered in Seoul, South Korea.
-
What is the size of CellArtgen?
CellArtgen has 21 total employees.
-
What industry is CellArtgen in?
CellArtgen’s primary industry is Biotechnology.
-
Is CellArtgen a private or public company?
CellArtgen is a Private company.
-
What is CellArtgen’s current revenue?
The current revenue for CellArtgen is .
-
How much funding has CellArtgen raised over time?
CellArtgen has raised $2.74M.
-
Who are CellArtgen’s investors?
iAccel (Seongnam-si), Moneyball Ventures, Ray (Diagnostic Equipment), Seoul National University Technology Holdings, and Yeonsei Technology Holdings are 5 of 6 investors who have invested in CellArtgen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process